Breast Implants in Turkey: Brand, Serial Number, Implant Card and Long-Term Follow-Up

Written by: Estexper Medical Editorial Team

Medically reviewed by: Mehmet Ozdemir, MD

Choosing breast implants in Turkey involves more than selecting a size or discussing the surgical technique. Long-term care also depends on receiving complete, reliable information about the exact devices placed during surgery. This information can be important if you need breast imaging, move to another country, consult a different surgeon, or require assessment of a possible complication years later.

In Short

Before leaving Turkey, request an implant card and operative records showing the manufacturer, model, size, fill, surface, serial or lot number, UDI where applicable, implantation date and facility.
Breast implants are not lifetime devices, so retain your records permanently and follow the manufacturer’s labeling and your clinician’s follow-up advice.
For silicone gel-filled implants, FDA labeling recommendations advise ultrasound or MRI from 5–6 years after surgery and every 2–3 years thereafter for asymptomatic patients.
Persistent swelling, a mass, pain or late fluid around an implant should be assessed by a qualified healthcare professional.

At Estexper Clinic, patients should discuss documentation and follow-up expectations with the treating medical team before surgery. Individual suitability for breast implants and the choice of implant must always be assessed by a qualified physician.

Why implant documentation matters

Brand name alone is not enough to identify a breast implant. A manufacturer may produce several product families, shapes, sizes, fill types and surface designs. The same brand can therefore refer to devices with different clinical characteristics and labeling instructions.

Accurate documentation creates a durable link between you and the specific devices used in your operation. It can help future healthcare professionals:

Identify the manufacturer and product family or model
Confirm the implant size, fill type and surface type
Check the serial number, lot or batch number and UDI where applicable
Review product-specific warnings and follow-up instructions
Plan mammography, ultrasound, MRI or revision surgery more appropriately
Investigate a possible device issue or complication

This is particularly important for international patients who may return home shortly after surgery. A future doctor may not have direct access to the Turkish clinic’s records. Keeping the original documents permanently and showing them to healthcare professionals can make future care more efficient.

What should be included on a breast implant card?

An implant card should allow the device to be identified without relying only on memory or a general brand name. Under Turkish and European implant-card guidance, the information should generally include:

Device name or type
Manufacturer name and contact or website information
Product family, model, style or reference information
Implant size
Fill type, such as silicone gel-filled or another specified type
Surface type, including whether the implant is smooth or textured where relevant
Serial number or lot or batch number
Unique Device Identifier, or UDI, where applicable
Date of implantation
Patient identification information, as required
Name or details of the healthcare institution where the procedure was performed
Relevant warnings, expected device lifetime and necessary follow-up information

Patients should also request a copy of the operative report and any other implant documentation provided by the clinic or surgeon. The card and records should be available in Turkish and, where necessary, English so that they can be understood and used during care in another country.

Serial number, lot number and UDI: what is the difference?

The serial number or lot number is a key part of traceability. A serial number may identify an individual device, while a lot or batch number may identify a group of devices manufactured together. A UDI is a standardized identifier that can contain information about the device type and production details. The exact format and availability may vary by product and regulatory requirements.

Ask the clinic to explain which identifiers apply to your implants and ensure that both the left and right implant details are recorded if they are different. Keep photographs or scans of the card in a secure digital location, but retain the original document as well.

How to choose an implant brand in Turkey

Patients often search for the “best” breast implant brand. However, there is no single brand that is universally safest or most suitable for every person. A responsible decision should consider the implant’s regulatory status, product-specific labeling, model, size, fill, surface, clinical indication and the patient’s anatomy and goals.

During consultation, the surgeon may discuss how different implant characteristics relate to the proposed procedure. Important questions include:

Which manufacturer and product family are being recommended?
What are the model, size, fill and surface details?
Why is this particular implant appropriate for my anatomy and surgical plan?
What follow-up does the manufacturer recommend?
What warnings or limitations appear in the product labeling?
Will the exact serial or lot number be recorded on my implant card and operative report?

Patients should be cautious of claims that one brand guarantees a permanent result or eliminates the need for future surgery. Breast implants are not lifetime devices, and the decision should be based on an individualized medical assessment rather than brand marketing alone.

Preparing for surgery and returning home

Preparation should include both medical planning and documentation planning. Before travelling, international patients should provide the clinic with relevant medical information and discuss any previous breast surgery, implants, imaging, diagnoses or treatment. The surgeon will determine whether breast implants are appropriate and whether additional evaluation is needed.

Before the procedure, ask for written information about:

The proposed surgical plan and implant characteristics
Expected recovery and follow-up arrangements
Potential complications and the possibility of additional surgery
How and when the implant card will be issued
Who to contact after returning home
What to do if symptoms develop during travel or after returning home

Do not leave Turkey without checking that your name, implantation date, facility details and device information are correct. If the clinic provides separate labels or stickers for each implant, ask that these are included in your records.

Recovery and early aftercare

Early recovery instructions depend on the operation and the treating surgeon’s assessment. Patients should follow the clinic’s written advice about wound care, activity, medication and scheduled reviews. International patients should make sure they understand how to contact the clinic after returning home and whether a local healthcare professional should participate in follow-up.

Seek medical advice promptly if you develop concerning symptoms such as increasing pain, significant swelling, redness, drainage, fever or an unexpected change in breast appearance. The appropriate response depends on the examination and clinical circumstances. Keep your implant card available if you attend another clinic or hospital.

Long-term follow-up: implants are not lifetime devices

Breast implants are not considered lifetime devices. The longer an implant remains in place, the greater the possibility of complications such as rupture and the potential need for additional surgery. However, there is no universally predictable replacement date that applies to every patient. Some people may require revision earlier because of symptoms or complications, while others may not need surgery for many years.

Possible complications include:

Capsular contracture, in which scar tissue around the implant becomes firm or tight
Rupture or leakage
Pain or persistent discomfort
Infection
Changes in breast shape, position or symmetry
Rippling or visible or palpable implant edges
Need for revision or implant removal surgery

These risks do not mean that every patient will experience a complication. They explain why patients should retain complete records and follow product-specific and clinician-recommended monitoring.

Imaging after silicone gel-filled implants

For silicone gel-filled implants, FDA labeling recommendations advise ultrasound or MRI beginning 5–6 years after implantation and repeating imaging every 2–3 years in asymptomatic patients. MRI is recommended when symptoms are present or when ultrasound findings are inconclusive. These recommendations concern surveillance for possible rupture and should be discussed with the treating clinician and considered alongside the specific manufacturer’s instructions.

FDA recommendations are not automatically Turkish legal requirements. Patients should therefore confirm the appropriate schedule with their surgeon, radiologist and local healthcare provider. The medical team may adapt the plan according to symptoms, examination findings, implant characteristics and local guidance.

Breast implant imaging does not replace routine breast-cancer screening. Mammography and other screening should continue according to the recommendations that apply to the patient’s age and personal risk. Always tell the imaging facility that you have breast implants and provide your implant details when requested. The facility may use specific techniques and should consider the presence of implants when planning the examination.

Recognizing possible BIA-ALCL symptoms

Breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, is a rare implant-associated T-cell lymphoma. Available evidence indicates that it is associated more strongly with textured implants than with smooth implants. Risk estimates vary across implant types and populations, so patients should not interpret the diagnosis as an inevitable consequence of having an implant.

BIA-ALCL commonly presents years after implantation with one or more of the following:

Persistent swelling of the breast
A mass in the breast or around the implant
Persistent pain
A late peri-implant fluid collection, sometimes called a late seroma

These symptoms can have causes other than BIA-ALCL, but they should be assessed by a qualified healthcare professional. Tell the clinician that you have breast implants and provide the manufacturer, model, surface type and serial or lot number if available. The implant card can help the medical team determine the appropriate evaluation.

Current FDA guidance does not recommend routine removal of breast implants in patients without symptoms solely because of the risk of BIA-ALCL. If you are concerned about your implant surface or have persistent changes, discuss the situation with a qualified surgeon rather than arranging removal based only on general information.

What if your implant card is missing?

If you did not receive an implant card, or if the card is incomplete, contact the original clinic or surgeon as soon as possible. Request the complete implant record, including the operative report and device labels. Ask specifically for the manufacturer, model or style, size, fill type, surface, serial or lot number, UDI where applicable, implantation date and facility details.

If the clinic cannot immediately provide the records, keep copies of all correspondence and inform any future healthcare professional that the documentation is incomplete. Do not guess the brand or model based on the appearance of the breasts or on a general invoice. Accurate records should come from the clinic, surgeon or manufacturer documentation.

A practical long-term checklist for international patients

Keep the original implant card permanently.
Save a secure digital copy of the card and operative report.
Record the exact implantation date and facility.
Know the manufacturer, model, size, fill and surface type.
Keep the serial or lot number and UDI where applicable.
Ask future imaging facilities to review your implant information.
Follow the manufacturer’s labeling and your clinician’s advice about rupture surveillance.
Continue routine breast-cancer screening as recommended.
Report persistent swelling, a mass, pain or other unexpected changes.
Bring your implant card to consultations, imaging appointments and any revision surgery assessment.

Frequently asked questions

Do breast implants need to be replaced after a fixed number of years?

There is no single replacement date that applies to everyone. Implants are not lifetime devices, and the chance of rupture or other complications may increase over time. Replacement or removal is considered according to symptoms, findings, implant condition, patient preference and the surgeon’s assessment.

Is the implant brand enough for future medical care?

No. The brand should be accompanied by the manufacturer, model or style, size, fill type, surface type, serial or lot number, UDI where applicable, implantation date and facility information.

Can I have mammography with breast implants?

Routine breast-cancer screening remains necessary when recommended for you. Tell the imaging facility about your implants before the examination so that the team can plan appropriately.

Should an asymptomatic patient remove textured implants because of BIA-ALCL?

Routine removal is not generally recommended solely because of BIA-ALCL risk when a patient has no symptoms. Discuss personal concerns and implant-specific information with a qualified physician.

Explore our Plastic Surgery services in Turkey for an overview of treatment options and individual assessment.

TREATMENT OPTIONS